Your browser doesn't support javascript.
loading
Correction to: SRRM2 may be a potential biomarker and immunotherapy target for multiple myeloma: a real-world study based on flow cytometry detection.
Guo, Jinjing; Zhang, Zhiye; Wang, Huiping; Li, Qian; Fan, Mengmeng; Zhang, Wanqiu; Tao, Qianshan; Wang, Zhitao; Ling, Chun; Xiao, Hao; Gao, Zhimai; Zhai, Zhimin.
Affiliation
  • Guo J; Department of Hematology, Hematological Research Center, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Zhang Z; Department of Laboratory, Fuyang People's Hospital, Fuyang, China.
  • Wang H; Department of Hematology, Hematological Research Center, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Li Q; Department of Hematology, Fuyang Hospital Affiliated to Anhui Medical University, Fuyang, China.
  • Fan M; Department of Hematology, Hematological Research Center, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Zhang W; Department of Hematology, Hematological Research Center, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Tao Q; Department of Hematology, Hematological Research Center, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Wang Z; Department of Hematology, Hematological Research Center, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Ling C; Department of Hematology, Hematological Research Center, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Xiao H; Department of Hematology, Hematological Research Center, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Gao Z; Department of Hematology, Hematological Research Center, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Zhai Z; Department of Hematology, Affiliated Chuzhou Hospital of Anhui Medical University, Chuzhou, Anhui, China.
Clin Exp Med ; 24(1): 159, 2024 Jul 18.
Article de En | MEDLINE | ID: mdl-39023571

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Clin Exp Med Sujet du journal: MEDICINA Année: 2024 Type de document: Article Pays d'affiliation: Chine

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Clin Exp Med Sujet du journal: MEDICINA Année: 2024 Type de document: Article Pays d'affiliation: Chine